Recent Media & Articles
Zacks Small Cap Research
August 14, 2024
INAB: AML & GBM Clinical Update
Kuick Research
August 10, 2024
Safety and Efficacy Profiles of Gamma Delta T Cell-Based Therapies
Forbes
August 7, 2024
Father Of CAR T-Cell Therapy Sees 2024 As A Breakthrough Year For Brain Cancer Treatment
Nature Cancer
July 26, 2024
γδ T cells as Critical Anti-Tumor Immune Effectors
Zacks Small Cap Research
June 17, 2024
INAB: Initiating Coverage – Enhancing the Insurgents of the Immune System
CGT Live
June 13, 2024
IN8bio’s Gamma-Delta T-cell Therapy INB-100 Helps Maintain Complete Remissions After HSCT in Patients With Hematologic Malignancies
Zacks Small Cap Research
April 22, 2024
INAB: Initiating Coverage – Enhancing the Insurgents of the Immune System
Pharmaceutical Technology
March 2, 2024
Development of Gamma-Delta T-Cell Therapies
Drug Target Review
February 28, 2024
Gamma delta T cells: a rising star in cancer therapy
Benzinga
January 22, 2024
IIN8bio’s Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
Benzinga
November 27, 2024
Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio’s Innovative Approach
PharmaExec
November 20, 2023
New Ways to Battle Cancer: Q&A With William Ho, CEO of IN8bio
Benzinga
November 2, 2023
How IN8bio Is Working To Reach Its Goal Of “Cancer Zero” – Making Cancer A Thing of The Past
Stat News
October 6, 2023
Long underappreciated, gamma-delta T cells may be key to colon cancer defense, study says
Trends in Cancer
September 23, 2023
Wargaming cancer: a strategy for future precision oncology?
Kuick Research
May 5, 2022
Gamma Delta T Cell Cancer Therapy Market Trends Forecast 2028